Unleash hidden spectral data for future smart skin care and personalized recommendations on the AI-based mobile platform.
HANGZHOU,China,Aug. 28,2024-- Hangzhou Tigermed Consulting Co.,Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK),a leading provider of clinical research solution
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SUZHOU,China,Aug. 28,2024--Harbour BioMed ("HBM",or the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the disco
"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®"
Revenues increased to RMB2.04 billion,representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million,from an adjusted net loss of RMB17.4 million in the same period of 2023
SUZHOU,China,Aug. 28,2024-- Peijia Medical (HKG:9996),a leading Chinese domestic player in the high-growth transcatheter valve therapeuticsand neurovascular interventions markets,announced that its w
